Merit Medical Systems, Inc. (NASDAQ:MMSI) Director F. Ann Millner sold 3,106 shares of the company’s stock in a transaction on Thursday, August 3rd. The stock was sold at an average price of $41.01, for a total transaction of $127,377.06. Following the completion of the transaction, the director now owns 6,750 shares of the company’s stock, valued at $276,817.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

F. Ann Millner also recently made the following trade(s):

  • On Wednesday, June 28th, F. Ann Millner sold 6,744 shares of Merit Medical Systems stock. The stock was sold at an average price of $38.15, for a total transaction of $257,283.60.

Merit Medical Systems, Inc. (MMSI) traded up 2.60% during mid-day trading on Monday, reaching $42.40. 531,154 shares of the company’s stock traded hands. Merit Medical Systems, Inc. has a one year low of $20.70 and a one year high of $42.50. The firm’s 50-day moving average price is $37.83 and its 200 day moving average price is $32.25. The firm has a market cap of $2.12 billion, a price-to-earnings ratio of 60.40 and a beta of 1.26.

Merit Medical Systems (NASDAQ:MMSI) last announced its earnings results on Wednesday, July 26th. The medical instruments supplier reported $0.36 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.29 by $0.07. The firm had revenue of $186.50 million for the quarter, compared to analysts’ expectations of $181.46 million. Merit Medical Systems had a net margin of 4.87% and a return on equity of 9.78%. The business’s revenue was up 23.4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.26 EPS. On average, equities analysts forecast that Merit Medical Systems, Inc. will post $1.26 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “Merit Medical Systems, Inc. (MMSI) Director Sells $127,377.06 in Stock” was originally reported by American Banking News and is the property of of American Banking News. If you are viewing this report on another domain, it was illegally copied and republished in violation of U.S. & international trademark & copyright law. The legal version of this report can be read at https://www.americanbankingnews.com/2017/08/07/merit-medical-systems-inc-mmsi-director-sells-127377-06-in-stock.html.

Several brokerages recently issued reports on MMSI. Piper Jaffray Companies reiterated a “buy” rating and issued a $45.00 target price on shares of Merit Medical Systems in a research report on Friday, July 28th. Bank of America Corporation began coverage on shares of Merit Medical Systems in a research report on Thursday, July 20th. They set a “buy” rating and a $44.00 price target for the company. Craig Hallum restated a “buy” rating and set a $50.00 price target (up from $42.00) on shares of Merit Medical Systems in a research report on Thursday, July 27th. BidaskClub upgraded shares of Merit Medical Systems from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. Finally, Sidoti restated a “buy” rating and set a $46.00 price target (up from $41.00) on shares of Merit Medical Systems in a research report on Wednesday, June 28th. One equities research analyst has rated the stock with a hold rating, eight have given a buy rating and one has given a strong buy rating to the company. The company has a consensus rating of “Buy” and an average target price of $39.74.

Hedge funds have recently made changes to their positions in the stock. BlackRock Inc. boosted its stake in shares of Merit Medical Systems by 7,837.9% in the first quarter. BlackRock Inc. now owns 6,789,527 shares of the medical instruments supplier’s stock valued at $196,218,000 after buying an additional 6,703,994 shares in the last quarter. Private Advisor Group LLC acquired a new stake in shares of Merit Medical Systems during the first quarter valued at about $444,000. Vanguard Group Inc. boosted its stake in shares of Merit Medical Systems by 16.1% in the first quarter. Vanguard Group Inc. now owns 4,186,883 shares of the medical instruments supplier’s stock valued at $121,001,000 after buying an additional 580,871 shares in the last quarter. Frontier Capital Management Co. LLC boosted its stake in shares of Merit Medical Systems by 24.8% in the second quarter. Frontier Capital Management Co. LLC now owns 2,737,303 shares of the medical instruments supplier’s stock valued at $104,428,000 after buying an additional 543,580 shares in the last quarter. Finally, MARSHALL WACE ASIA Ltd acquired a new stake in shares of Merit Medical Systems during the first quarter valued at about $15,657,000. Hedge funds and other institutional investors own 92.11% of the company’s stock.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Insider Buying and Selling by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.